-+ 0.00%
-+ 0.00%
-+ 0.00%

MAIA BIOTECHNOLOGY - TARGETS 100 PATIENTS DOSED IN THIO-104 BY YEAR-END 2026; INTERIM ANALYSIS IN 2027

Reuters·09/23/2026 13:17:00

Please log in to view news